- Schiava, Marianela;
- Ikenaga, Chiseko;
- Villar-Quiles, Rocío;
- Caballero-Ávila, Marta;
- Topf, Ana;
- Nishino, Ichizo;
- Kimonis, Virginia;
- Udd, Bjarne;
- Schoser, Benedikt;
- Zanoteli, Edmar;
- Souza, Paulo;
- Tasca, Giorgio;
- Lloyd, Thomas;
- Lopez-de Munain, Adolfo;
- Paradas, Carmen;
- Pegoraro, Elena;
- Nadaj-Pakleza, Aleksandra;
- De Bleecker, Jan;
- Badrising, Umesh;
- Alonso-Jiménez, Alicia;
- Kostera-Pruszczyk, Anna;
- Miralles, Francesc;
- Shin, Jin-Hong;
- Bevilacqua, Jorge;
- Olivé, Montse;
- Vorgerd, Matthias;
- Kley, Rudi;
- Brady, Stefen;
- Williams, Timothy;
- Domínguez-González, Cristina;
- Papadimas, George;
- Warman-Chardon, Jodi;
- Claeys, Kristl;
- de Visser, Marianne;
- Muelas, Nuria;
- LaForet, Pascal;
- Malfatti, Edoardo;
- Alfano, Lindsay;
- Nair, Sruthi;
- Manousakis, Georgios;
- Kushlaf, Hani;
- Harms, Matthew;
- Nance, Christopher;
- Ramos-Fransi, Alba;
- Rodolico, Carmelo;
- Hewamadduma, Channa;
- Cetin, Hakan;
- García-García, Jorge;
- Pál, Endre;
- Farrugia, Maria;
- Lamont, Phillipa;
- Quinn, Colin;
- Nedkova-Hristova, Velina;
- Peric, Stojan;
- Luo, Sushan;
- Oldfors, Anders;
- Taylor, Kate;
- Ralston, Stuart;
- Stojkovic, Tanya;
- Weihl, Conrad;
- Diaz-Manera, Jordi
BACKGROUND: Valosin-containing protein (VCP) disease, caused by mutations in the VCP gene, results in myopathy, Pagets disease of bone (PBD) and frontotemporal dementia (FTD). Natural history and genotype-phenotype correlation data are limited. This study characterises patients with mutations in VCP gene and investigates genotype-phenotype correlations. METHODS: Descriptive retrospective international study collecting clinical and genetic data of patients with mutations in the VCP gene. RESULTS: Two hundred and fifty-five patients (70.0% males) were included in the study. Mean age was 56.8±9.6 years and mean age of onset 45.6±9.3 years. Mean diagnostic delay was 7.7±6 years. Symmetric lower limb weakness was reported in 50% at onset progressing to generalised muscle weakness. Other common symptoms were ventilatory insufficiency 40.3%, PDB 28.2%, dysautonomia 21.4% and FTD 14.3%. Fifty-seven genetic variants were identified, 18 of these no previously reported. c.464G>A (p.Arg155His) was the most frequent variant, identified in the 28%. Full time wheelchair users accounted for 19.1% with a median time from disease onset to been wheelchair user of 8.5 years. Variant c.463C>T (p.Arg155Cys) showed an earlier onset (37.8±7.6 year) and a higher frequency of axial and upper limb weakness, scapular winging and cognitive impairment. Forced vital capacity (FVC) below 50% was as risk factor for being full-time wheelchair user, while FVC <70% and being a full-time wheelchair user were associated with death. CONCLUSION: This study expands the knowledge on the phenotypic presentation, natural history, genotype-phenotype correlations and risk factors for disease progression of VCP disease and is useful to improve the care provided to patient with this complex disease.